Previous Chapter Chapter 20: US Markets for Transcatheter Embolization and Occlusion Devices Next Chapter

  • Citations
  • Add to My List
  • Text Size

US Markets for Transcatheter Embolization and Occlusion Devices
US markets for transcatheter embolization and occlusion devices
Millennium Research Group, A Decision Resources, Inc. Company

The US transcatheter embolization and occlusion market was valued at over $250 million in 2004 and will increase at a CAGR of about 10% over the forecast period, as displayed in Exhibit 3.1. The adoption of new and innovative transcatheter embolization and occlusion technologies in interventional neuroradiology (INR), peripheral vascular (PV), and interventional cardiology (IC) procedures such as endovascular cerebral aneurysm coiling, microspheres, and heart defect closure devices will be the major drivers of revenue growth over the next few years. The transcatheter embolization and occlusion market will be limited by physician referral patterns, the lack of long-term clinical data for new technologies, ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website